Brilinta 90 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FX21F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,781
Award facts
- Contract value 100% obligated
- $1,780.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Brilinta 90 mg tablets (60-count packages) with a contract value of $1,780.51. This competitively awarded, firm fixed price delivery order is set to be completed by July 28, 2025, and represents performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation and is issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies critical medications to federal medical procurement programs, particularly for military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. Brilinta is an antiplatelet medication commonly used in cardiovascular treatment protocols, and this delivery order fulfills the company's role as a prime vendor for pharmaceutical support to defense health operations. The award reflects AmerisourceBergen's established capability to meet competitive federal procurement requirements across diverse therapeutic domains and reinforces its position as a key pharmaceutical supplier supporting DLA's global military healthcare logistics operations.
Quick answers
Who was awarded contract SPE2DB25FX21F?
SPE2DB25FX21F was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 25, 2025.
How much is contract SPE2DB25FX21F worth?
The government has obligated $1,781 on SPE2DB25FX21F.
Is contract SPE2DB25FX21F an order under another contract?
Yes. SPE2DB25FX21F is a delivery order under SPE2DB20D2200, an indefinite delivery contract.
Was contract SPE2DB25FX21F competed?
The extent of competition for SPE2DB25FX21F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award